Verastem (VSTM) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.30% |
| Dec 31, 2025 | 55.76% |
| Jun 30, 2024 | -9.03% |
| Mar 31, 2024 | 143.35% |
| Dec 31, 2023 | 15.97% |
| Sep 30, 2023 | -35.26% |
| Jun 30, 2023 | 95.30% |
| Mar 31, 2023 | -16.88% |
| Dec 31, 2022 | 23.63% |
| Sep 30, 2022 | -26.27% |
| Jun 30, 2022 | 15.84% |
| Mar 31, 2022 | 36.29% |
| Dec 31, 2021 | -41.77% |
| Sep 30, 2021 | 21.81% |
| Jun 30, 2021 | -40.13% |
| Mar 31, 2021 | -67.56% |
| Dec 31, 2020 | -48.52% |
| Sep 30, 2020 | 72.47% |
| Jun 30, 2020 | -14.90% |
| Mar 31, 2020 | 21.76% |
| Dec 31, 2019 | 13.26% |
| Sep 30, 2019 | 18.22% |
| Jun 30, 2019 | 21.02% |
| Mar 31, 2019 | -38.48% |
| Dec 31, 2018 | -116.36% |
| Sep 30, 2018 | 18.64% |
| Jun 30, 2018 | 41.91% |
| Mar 31, 2018 | -29.38% |
| Dec 31, 2017 | -1.62% |
| Sep 30, 2017 | 58.84% |
| Jun 30, 2017 | 37.98% |
| Mar 31, 2017 | 15.83% |
| Dec 31, 2016 | 15.18% |
| Sep 30, 2016 | 64.66% |
| Jun 30, 2016 | 132.57% |